Hans Renata and Alexander Adibekian of Scripps Research (IMAGE)

Scripps Research Institute

Hans Renata and Alexander Adibekian of Scripps Research

Caption

Chemists Hans Renata, PhD, and Alexander Adibekian, PhD, both of Scripps Research, say the bacterial extract cepafungin I is in the same class as several FDA-approved anti-cancer drugs, with some improved properties.

Credit

Scripps Research

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.